ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management

Thu, Nguyen Quang; Tien, Nguyen Tran Nam; Yen, Nguyen Thi Hai; Duong, Thuc-Huy; Long, Nguyen Phuoc*; Nguyen, Huy Truong*
Journal of Pharmaceutical Analysis2024-1DOI: 10.1016/j.jpha.2023.09.009
2被引4阅读
引用收藏
分享

摘要

The spread of tuberculosis (TB), especially multidrug-resistant TB and extensively drug -resistant TB, has strongly motivated the research and development of new anti -TB drugs. New strategies to facilitate drug combinations, including pharmacokinetics-guided dose optimization and toxicology studies of first- and second -line anti -TB drugs have also been introduced and recommended. Liquid chromatography -mass spectrometry (LC -MS) has arguably become the gold standard in the analysis of both endo- and exo-genous compounds. This technique has been applied successfully not only for therapeutic drug monitoring (TDM) but also for pharmacometabolomics analysis. TDM improves the effectiveness of treatment, reduces adverse drug reactions, and the likelihood of drug resistance development in TB patients by determining dosage regimens that produce concentrations within the therapeutic target Based on TDM, the dose would be optimized individually to achieve favorable outcomes. Pharmacometabolomics is essential in generating and validating hypotheses regarding the metabolism of anti -TB drugs, aiding in the discovery of potential biomarkers for TB diagnostics, treatment monitoring, and outcome evaluation. This article highlighted the current progresses in TDM of anti -TB drugs based on LC -MS bioassay in the last two decades. Besides, we discussed the advantages and disadvantages of this technique in practical use. The pressing need for non-invasive sampling approaches and stability studies of anti -TB drugs was highlighted. Lastly, we provided perspectives on the prospects of combining LC -MS -based TDM and pharmacometabolomics with other advanced strategies (pharmacometrics, drug and vaccine developments, machine learning/artificial intelligence, among others) to encapsulate in an all-inclusive approach to improve treatment outcomes of TB patients. (c) 2023 The Author(s). Published by Elsevier B.V. on behalf of Xi'an Jiaotong University. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

学科与关键词

关键词
TuberculosisTherapeutic drug monitoringLC-MSMIPDPharmacometabolomicsPrecision medicine
相关
加载中…
  • A Review of Clinical Pharmacokinetic and Pharmacodynamic Relationships and Clinical Implications for Drugs Used to Treat Multi-drug Resistant Tuberculosis
    Wilby, Kyle John*; Hussain, Farhat NazEUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45(3): 305-313.被引 5
  • Quantitative assessment of the activity of antituberculosis drugs and regimens
    Chirehwa, Maxwell T.*; Velasquez, Gustavo E.; Gumbo, Tawanda; McIlleron, HelenExpert Review of Anti-Infective Therapy, 2019, 17(6): 449-457.被引 3
  • The novel potential biomarkers for multidrug-resistance tuberculosis using UPLC-Q-TOF-MS
    Huang, Huai; Han, Yu-Shuai; Chen, Jing; Shi, Li-Ying; Wei, Li-Liang; Jiang, Ting-Ting; Yi, Wen-Jing; Yu, Yi; Li, Zhi-Bin; Li, Ji-Cheng*Experimental Biology and Medicine, 2020, 245(6): 501-511.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pharmaceutical Analysis
发表日期
2024-01
卷期
第 14 卷, 第 1 期
页码
16-38
DOI
10.1016/j.jpha.2023.09.009
成果收录
SCIE
资助标注
National Research Foundation of Korea (NRF) - Korean government (MSIT) [2018R1A5A2021242]

作者

  • T

    Thu, Nguyen Quang (第一作者)

  • T

    Tien, Nguyen Tran Nam

查看全部 6 位作者收起作者
  • Y

    Yen, Nguyen Thi Hai

  • D

    Duong, Thuc-Huy

  • L

    Long, Nguyen Phuoc (通讯)

  • N

    Nguyen, Huy Truong (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417